Cargando…
Recent advances in the management of pediatric acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. Despite enormous improvement of prognosis during the last half century, ALL remains a major cause of childhood cancer-related mortality. During the past decade, whole genomic methods have enhanced our knowledge of disease...
Autores principales: | Starý, Jan, Hrušák, Ondřej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642309/ https://www.ncbi.nlm.nih.gov/pubmed/29098074 http://dx.doi.org/10.12688/f1000research.9548.1 |
Ejemplares similares
-
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
por: Zaliova, Marketa, et al.
Publicado: (2019) -
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
por: Kalina, Tomas, et al.
Publicado: (2005) -
A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
por: Drożak, Paulina, et al.
Publicado: (2022) -
Recent advances on blinatumomab for acute lymphoblastic leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019) -
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)